Home Stock

Stock Research: AbbVie

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

AbbVie

NYQ:ABBV US00287Y1091
1
  • Value
    56
  • Growth
    41
  • Safety
    Safety
    10
  • Combined
    1
  • Sentiment
    96
  • 360° View
    360° View
    1
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

AbbVie Inc. is a global biopharmaceutical company focused on research, development, manufacturing, and commercialization of medicines and therapies. Key areas include Immunology, Oncology, Aesthetics, Neuroscience, and Eye Care. In the last fiscal year, the company had a market cap of $329,240 million, profits of $39,430 million, revenue of $56,334 million, and 55000 employees.

more
Strongest Rank 360° View
Weakest Rank Dividend Yield
Country USA
Industry Biotechnology
Size XX-Large
Website abbvie.com
Index
D.J. US Health Care
S&P 500
AbbVie stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
56 72 n/a n/a
Growth
41 35 n/a n/a
Safety
Safety
10 36 n/a n/a
Sentiment
96 96 n/a n/a
360° View
360° View
1 75 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
15 35 n/a n/a
Opinions Change
81 70 n/a n/a
Pro Holdings
n/a 94 n/a n/a
Market Pulse
86 85 n/a n/a
Sentiment
96 96 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
56 72 n/a n/a
Growth
41 35 n/a n/a
Safety Safety
10 36 n/a n/a
Combined
1 43 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
48 28 n/a n/a
Price vs. Earnings (P/E)
57 61 n/a n/a
Price vs. Book (P/B)
1 1 n/a n/a
Dividend Yield
100 100 n/a n/a
Value
56 72 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
34 35 n/a n/a
Profit Growth
90 53 n/a n/a
Capital Growth
10 33 n/a n/a
Stock Returns
53 59 n/a n/a
Growth
41 35 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
15 9 n/a n/a
Refinancing
4 5 n/a n/a
Liquidity
78 92 n/a n/a
Safety Safety
10 36 n/a n/a

Similar Stocks

Discover high‑ranked alternatives to AbbVie and broaden your portfolio horizons.

Sandisk

NSQ:SNDK
Country: USA
Industry: Technology Hardware & Peripherals
Size: X-Large
Full Stock Analysis

Walt Disney

NYQ:DIS
Country: USA
Industry: Movies & Entertainment
Size: XX-Large
Full Stock Analysis

Salesforce

NYQ:CRM
Country: USA
Industry: Application Software
Size: XX-Large
Full Stock Analysis

Franklin Resources

NYQ:BEN
Country: USA
Industry: Asset Management & Custody
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The only strength is good value. All other factors (growth, safety, and sentiment) are below average. This stock is highly sensitive to a crisis and is not advisable. Avoid unless you have solid, independent reasons to believe a significant turnaround is imminent.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews